Coronary Artery Disease Clinical Trial
Official title:
The Effect Of An Expanded Long Term Periodization Exercise Training In Patients With Cardiovascular Disease: Central And Peripheral Adaptations
Verified date | March 2020 |
Source | University of Lisbon |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Benefits from cardiac rehabilitation (CR) programs are evidence based and widely recognized.
Less than 50% of people who participate in hospital-based CR programs maintain an exercise
regimen for as long as six months after completion. Despite the benefits associated with
regular exercise training (ET), adherence with supervised exercise-based CR remains low.
Current exercise guidelines for CR focus on moderate intensity steady state exercises, with
walking and cycling being the most recommended types of ET. The repetitive nature of this
type of activity can become monotonous for the patient, affecting exercise adherence,
compliance and training outcomes. Exercise periodization is a method typically used in sports
training, but the impact of periodized exercise to yield optimal beneficial effects in
cardiac patients is still unclear.
In healthy or trained populations, periodization aims to optimize ET adaptations as compared
with non periodized training, to prevent overtraining and to avoid plateauing of training
adaptations. Periodized methods are considered to be superior to non periodized methods in
trained populations and appears to be superior in inactive adults. In most of the CR programs
there are no periodization or exercise progression during medium to long term interventions.
Further randomized controlled trials (RCT) are necessary to evaluate long-term periodization
outcomes.
The purpose of this research project is twofold:
1. To conduct a 12-month randomized control trial to evaluate the effects of a periodized
ET regime versus a non periodized ET regime (guidelines) on VO2 peak, maximal strength,
body composition, functionality and quality of life in cardiovascular disease patients.
2. to differentiate the effects of a 12-month periodized ET regime versus a non periodized
ET regime on the different components of the oxygen kinetics response and oxidative
adaptations in cardiovascular disease patients.
These patients will be randomized in 2 ET groups: 1) periodization; 2) non periodization.
This experimental design will occur during 48 weeks 3 times per week with 4 assessment time
points: M0) before starting the ET program (baseline); M1) 3 months after starting the ET;
M2) 6 months after starting the ET program and M3) 12 months at the end of the
community-based ET program.
Status | Completed |
Enrollment | 50 |
Est. completion date | December 20, 2019 |
Est. primary completion date | December 20, 2019 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - angiographically documented coronary artery disease in at least one major epicardial vessel - myocardial infarction, - coronary revascularization (coronary artery bypass grafting, percutaneous transluminal coronary angioplasty, or coronary artery stent), Exclusion Criteria: - heart failure - unstable angina pectoris - heart transplants with either cardiac resynchronization therapy or implantable defibrillators - inability to comply with guidelines for participation in exercise testing and training - significant limiting and/or unstable comorbidities that would prevent full participation |
Country | Name | City | State |
---|---|---|---|
Portugal | Faculty of Human Kinetics - University of Lisbon | Lisbon | Cruz Quebrada |
Lead Sponsor | Collaborator |
---|---|
University of Lisbon |
Portugal,
Anderson L, Oldridge N, Thompson DR, Zwisler AD, Rees K, Martin N, Taylor RS. Exercise-Based Cardiac Rehabilitation for Coronary Heart Disease: Cochrane Systematic Review and Meta-Analysis. J Am Coll Cardiol. 2016 Jan 5;67(1):1-12. doi: 10.1016/j.jacc.2015.10.044. Review. — View Citation
Balady GJ, Arena R, Sietsema K, Myers J, Coke L, Fletcher GF, Forman D, Franklin B, Guazzi M, Gulati M, Keteyian SJ, Lavie CJ, Macko R, Mancini D, Milani RV; American Heart Association Exercise, Cardiac Rehabilitation, and Prevention Committee of the Council on Clinical Cardiology; Council on Epidemiology and Prevention; Council on Peripheral Vascular Disease; Interdisciplinary Council on Quality of Care and Outcomes Research. Clinician's Guide to cardiopulmonary exercise testing in adults: a scientific statement from the American Heart Association. Circulation. 2010 Jul 13;122(2):191-225. doi: 10.1161/CIR.0b013e3181e52e69. Epub 2010 Jun 28. Review. — View Citation
Conlon JA, Newton RU, Tufano JJ, Banyard HG, Hopper AJ, Ridge AJ, Haff GG. Periodization Strategies in Older Adults: Impact on Physical Function and Health. Med Sci Sports Exerc. 2016 Dec;48(12):2426-2436. — View Citation
Elliott AD, Rajopadhyaya K, Bentley DJ, Beltrame JF, Aromataris EC. Interval training versus continuous exercise in patients with coronary artery disease: a meta-analysis. Heart Lung Circ. 2015 Feb;24(2):149-57. doi: 10.1016/j.hlc.2014.09.001. Epub 2014 Sep 16. Review. — View Citation
Humphrey R, Guazzi M, Niebauer J. Cardiac rehabilitation in Europe. Prog Cardiovasc Dis. 2014 Mar-Apr;56(5):551-6. doi: 10.1016/j.pcad.2013.08.004. Epub 2013 Oct 5. Review. — View Citation
Liou K, Ho S, Fildes J, Ooi SY. High Intensity Interval versus Moderate Intensity Continuous Training in Patients with Coronary Artery Disease: A Meta-analysis of Physiological and Clinical Parameters. Heart Lung Circ. 2016 Feb;25(2):166-74. doi: 10.1016/j.hlc.2015.06.828. Epub 2015 Jul 22. Review. — View Citation
Madssen E, Arbo I, Granøien I, Walderhaug L, Moholdt T. Peak oxygen uptake after cardiac rehabilitation: a randomized controlled trial of a 12-month maintenance program versus usual care. PLoS One. 2014 Sep 23;9(9):e107924. doi: 10.1371/journal.pone.0107924. eCollection 2014. — View Citation
Marzolini S, Oh PI, Brooks D. Effect of combined aerobic and resistance training versus aerobic training alone in individuals with coronary artery disease: a meta-analysis. Eur J Prev Cardiol. 2012 Feb;19(1):81-94. doi: 10.1177/1741826710393197. Epub 2011 Feb 21. Review. — View Citation
Piepoli MF, Hoes AW, Agewall S, Albus C, Brotons C, Catapano AL, Cooney MT, Corrà U, Cosyns B, Deaton C, Graham I, Hall MS, Hobbs FDR, Løchen ML, Löllgen H, Marques-Vidal P, Perk J, Prescott E, Redon J, Richter DJ, Sattar N, Smulders Y, Tiberi M, van der Worp HB, van Dis I, Verschuren WMM, Binno S; ESC Scientific Document Group. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts)Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J. 2016 Aug 1;37(29):2315-2381. doi: 10.1093/eurheartj/ehw106. Epub 2016 May 23. — View Citation
Rhea MR, Alderman BL. A meta-analysis of periodized versus nonperiodized strength and power training programs. Res Q Exerc Sport. 2004 Dec;75(4):413-22. — View Citation
Shepherd CW, While AE. Cardiac rehabilitation and quality of life: a systematic review. Int J Nurs Stud. 2012 Jun;49(6):755-71. doi: 10.1016/j.ijnurstu.2011.11.019. Epub 2011 Dec 23. Review. — View Citation
Strohacker K, Fazzino D, Breslin WL, Xu X. The use of periodization in exercise prescriptions for inactive adults: A systematic review. Prev Med Rep. 2015 May 6;2:385-96. doi: 10.1016/j.pmedr.2015.04.023. eCollection 2015. Review. — View Citation
Yamamoto S, Hotta K, Ota E, Mori R, Matsunaga A. Effects of resistance training on muscle strength, exercise capacity, and mobility in middle-aged and elderly patients with coronary artery disease: A meta-analysis. J Cardiol. 2016 Aug;68(2):125-34. doi: 10.1016/j.jjcc.2015.09.005. Epub 2015 Dec 12. — View Citation
* Note: There are 13 references in all — Click here to view all references
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Change of six minute walking test distance | The six minute walking test (6MWT) will be performed indoors, along a long flat, straight, enclosed 20-meter corridor with a hard surface that is seldom. Total distance during the test will be recorded. | At baseline, 3 months after starting the ET, 6 months after starting the ET and 12 months after starting the ET | |
Other | Change of 30-second chair stand repetitions | The 30-second chair stand, assesses the lower body strength, needed for numerous tasks such as climbing stairs or walking. | At baseline, 3 months after starting the ET, 6 months after starting the ET and 12 months after starting the ET | |
Other | Change of 8-foot up and go test duration | The 8-foot (2.44 meters) up and go test evaluates the agility/dynamic balance, which is important in tasks that require quick maneuvering. | At baseline, 3 months after starting the ET, 6 months after starting the ET and 12 months after starting the ET | |
Other | Change of chair sit-and-reach distance reached | For the flexibility for the lower limbs it will be assessed the chair sit-and-reach. | At baseline, 3 months after starting the ET, 6 months after starting the ET and 12 months after starting the ET | |
Other | Change of back scratch test distance reached | For the flexibility for the upper limbs it will be assessed the back scratch test. | At baseline, 3 months after starting the ET, 6 months after starting the ET and 12 months after starting the ET | |
Primary | Change of peak oxygen consumption during cardiopulmonary exercise testing | A symptom-limited ramp incremental cardiopulmonary exercise test, will be performed on a cycle ergometer (Ergostik, Geratherm Respiratory GmbH, Germany) with breath-by-breath gas exchange measurements. Each patient will be encouraged to exercise to exhaustion (20 Watt+20 Watt/min or 15 Watt+15 Watt/min or 10 Watt+10 Watt/min), as defined by intolerance, leg fatigue or dyspnea unless clinical criteria for test termination occurred. Peak oxygen capacity will be considered the highest attained VO2 during the final 30s of exercise. All patients should achieve a respiratory exchange ratio of >1.1, an indicator of maximal effort. | At baseline, 3 months after starting the ET, 6 months after starting the ET and 12 months after starting the ET | |
Primary | Change of oxygen kinetics during submaximal test | The test load is set at 80% of the value of the work rate corresponding to the Anaerobic Threshold detected in the maximum test, which was performed first, or 50% of VO2 peak, if the Anaerobic Threshold could not be adequately determined. Cardiopulmonary data will be recorded for 5 minutes at rest followed by 1 minute unloaded pedaling. After unloaded pedaling, patients will perform the constant load test for 6 min at the work rate described above, followed by unloaded pedaling for 5min. To improve the confidence of the kinetic parameter determination, this test will be performed three times and the averaged profile will be used for the kinetic analysis. | At baseline, 3 months after starting the ET, 6 months after starting the ET and 12 months after starting the ET | |
Secondary | Change of Anaerobic Threshold VO2 during cardiopulmonary exercise testing | Change in VO2 reached at the maximal cardiopulmonary exercise test at the Anaerobic Threshold. | At baseline, 3 months after starting the ET, 6 months after starting the ET and 12 months after starting the ET | |
Secondary | Change of Anaerobic Threshold Heart Rate during cardiopulmonary exercise testing | Change in heart rate reached at the maximal cardiopulmonary exercise test at the Anaerobic Threshold. | At baseline, 3 months after starting the ET, 6 months after starting the ET and 12 months after starting the ET | |
Secondary | Change of Anaerobic Threshold Watts during cardiopulmonary exercise testing | Change in watts reached at the maximal cardiopulmonary exercise test at the Anaerobic Threshold. | At baseline, 3 months after starting the ET, 6 months after starting the ET and 12 months after starting the ET | |
Secondary | Change of Respiratory Compensation Point VO2 during cardiopulmonary exercise testing | Change in VO2 reached at the maximal cardiopulmonary exercise test at the Respiratory Compensation Point. | At baseline, 3 months after starting the ET, 6 months after starting the ET and 12 months after starting the ET | |
Secondary | Change of Respiratory Compensation Point Heart Rate during cardiopulmonary exercise testing | Change in heart rate reached at the maximal cardiopulmonary exercise test at the Respiratory Compensation Point. | At baseline, 3 months after starting the ET, 6 months after starting the ET and 12 months after starting the ET | |
Secondary | Change of Respiratory Compensation Point Watts during cardiopulmonary exercise testing | Change in watts reached at the maximal cardiopulmonary exercise test at the Respiratory Compensation Point. | At baseline, 3 months after starting the ET, 6 months after starting the ET and 12 months after starting the ET | |
Secondary | Change of Peak Heart Rate reached during cardiopulmonary exercise testing | Maximal heart rate reached at the cardiopulmonary exercise testing. | At baseline, 3 months after starting the ET, 6 months after starting the ET and 12 months after starting the ET | |
Secondary | Change of Maximal Watts reached during cardiopulmonary exercise testing | Maximal watts reached at the cardiopulmonary exercise testing. | At baseline, 3 months after starting the ET, 6 months after starting the ET and 12 months after starting the ET | |
Secondary | Change of Deoxyhaemoglobin of the vastus lateralis muscle at the submaximal test | The muscle deoxygenation dynamics of the Vastus Lateralis muscle will be evaluated throughout the submaximal CPET. Deoxyhaemoglobin (HHb) concentration will be quantified with a continuous-wave tissue oximeter (NIMO, Nirox srl, Brescia, Italy), based on the Near-infrared Spectroscopy (NIRS) system, which provides continuous, non-invasive monitoring of the relative concentration changes in these variables during rest and exercise. | At baseline, 3 months after starting the ET, 6 months after starting the ET and 12 months after starting the ET | |
Secondary | Change of Oxyhaemoglobin of the vastus lateralis muscle at the submaximal test | The muscle deoxygenation dynamics of the Vastus Lateralis muscle will be evaluated throughout the submaximal CPET. Oxyhaemoglobin (HbO2) concentration will be quantified with a continuous-wave tissue oximeter (NIMO, Nirox srl, Brescia, Italy), based on the Near-infrared Spectroscopy (NIRS) system, which provides continuous, non-invasive monitoring of the relative concentration changes in these variables during rest and exercise. | At baseline, 3 months after starting the ET, 6 months after starting the ET and 12 months after starting the ET | |
Secondary | Change of Total Haemoglobin of the vastus lateralis muscle at the submaximal test | The muscle deoxygenation dynamics of the Vastus Lateralis muscle will be evaluated throughout the submaximal CPET. Total haemoglobin (HbT) concentration will be quantified with a continuous-wave tissue oximeter (NIMO, Nirox srl, Brescia, Italy), based on the Near-infrared Spectroscopy (NIRS) system, which provides continuous, non-invasive monitoring of the relative concentration changes in these variables during rest and exercise. | At baseline, 3 months after starting the ET, 6 months after starting the ET and 12 months after starting the ET | |
Secondary | Change of Maximal Strength | Maximal strength will be assessed by 1 Repetition Maximum (1RM) test for each of six weight exercises on variable resistance machines as follows: leg press, leg extension, leg curl, low row, chest press and lat pull down. The protocol will include four pre-test sessions to familiarize each patient with the test procedures. Correct exercise and breathing techniques (avoidance of the Valsalva manoeuvre) will be practiced. | At baseline, 3 months after starting the ET, 6 months after starting the ET and 12 months after starting the ET | |
Secondary | Change of Lean Soft-Tissue | Total and regional lean soft-tissue will be estimated using dual energy radiographic absorptiometry (DXA) (Hologic Explorer-W, fan-beam densitometer, software QDR for windows version 12.4, Hologic, USA). | At baseline, 3 months after starting the ET, 6 months after starting the ET and 12 months after starting the ET | |
Secondary | Change of Fat Mass | Total and regional body mass fat mass will be estimated using dual energy radiographic absorptiometry (DXA) (Hologic Explorer-W, fan-beam densitometer, software QDR for windows version 12.4, Hologic, USA). | At baseline, 3 months after starting the ET, 6 months after starting the ET and 12 months after starting the ET | |
Secondary | Change of Bone Mineral Content | Total bone mineral content will be estimated using dual energy radiographic absorptiometry (DXA) (Hologic Explorer-W, fan-beam densitometer, software QDR for windows version 12.4, Hologic, USA). | At baseline, 3 months after starting the ET, 6 months after starting the ET and 12 months after starting the ET | |
Secondary | Change of Quality of Life | The Short Form-36 Health Survey (SF-36) is a self-assessment health status questionnaire composed of 36 questions about socio-demographic, health and personal behavior. A Portuguese validated version of SF-36 is available. | At baseline, 3 months after starting the ET, 6 months after starting the ET and 12 months after starting the ET |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06030596 -
SPECT Myocardial Blood Flow Quantification for Diagnosis of Ischemic Heart Disease Determined by Fraction Flow Reserve
|
||
Completed |
NCT04080700 -
Korean Prospective Registry for Evaluating the Safety and Efficacy of Distal Radial Approach (KODRA)
|
||
Recruiting |
NCT03810599 -
Patient-reported Outcomes in the Bergen Early Cardiac Rehabilitation Study
|
N/A | |
Recruiting |
NCT06002932 -
Comparison of PROVISIONal 1-stent Strategy With DEB Versus Planned 2-stent Strategy in Coronary Bifurcation Lesions.
|
N/A | |
Not yet recruiting |
NCT06032572 -
Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE)
|
N/A | |
Recruiting |
NCT04242134 -
Drug-coating Balloon Angioplasties for True Coronary Bifurcation Lesions
|
N/A | |
Recruiting |
NCT05308719 -
Nasal Oxygen Therapy After Cardiac Surgery
|
N/A | |
Completed |
NCT04556994 -
Phase 1 Cardiac Rehabilitation With and Without Lower Limb Paddling Effects in Post CABG Patients.
|
N/A | |
Recruiting |
NCT05846893 -
Drug-Coated Balloon vs. Drug-Eluting Stent for Clinical Outcomes in Patients With Large Coronary Artery Disease
|
N/A | |
Recruiting |
NCT06027788 -
CTSN Embolic Protection Trial
|
N/A | |
Recruiting |
NCT05023629 -
STunning After Balloon Occlusion
|
N/A | |
Completed |
NCT04941560 -
Assessing the Association Between Multi-dimension Facial Characteristics and Coronary Artery Diseases
|
||
Completed |
NCT04006288 -
Switching From DAPT to Dual Pathway Inhibition With Low-dose Rivaroxaban in Adjunct to Aspirin in Patients With Coronary Artery Disease
|
Phase 4 | |
Completed |
NCT01860274 -
Meshed Vein Graft Patency Trial - VEST
|
N/A | |
Recruiting |
NCT06174090 -
The Effect of Video Education on Pain, Anxiety and Knowledge Levels of Coronary Bypass Graft Surgery Patients
|
N/A | |
Terminated |
NCT03959072 -
Cardiac Cath Lab Staff Radiation Exposure
|
||
Completed |
NCT03968809 -
Role of Cardioflux in Predicting Coronary Artery Disease (CAD) Outcomes
|
||
Recruiting |
NCT04566497 -
Assessment of Adverse Outcome in Asymptomatic Patients With Prior Coronary Revascularization Who Have a Systematic Stress Testing Strategy Or a Non-testing Strategy During Long-term Follow-up.
|
N/A | |
Recruiting |
NCT05065073 -
Iso-Osmolar vs. Low-Osmolar Contrast Agents for Optical Coherence Tomography
|
Phase 4 | |
Completed |
NCT05096442 -
Compare the Safety and Efficacy of Genoss® DCB and SeQuent® Please NEO in Korean Patients With Coronary De Novo Lesions
|
N/A |